Publication — IRIC

Overview of the COVID-19 text mining tool interactive demonstration track in BioCreative VII.

The coronavirus disease 2019 (COVID-19) pandemic has compelled biomedical researchers to communicate data in real time to establish more effective medical treatments and public health policies. Nontraditional sources such as preprint publications, i.e. articles not yet validated by peer review, have become crucial hubs for the dissemination of scientific results. Natural language processing (NLP) systems have been recently developed to extract and organize COVID-19 data in reasoning systems. Given this scenario, the BioCreative COVID-19 text mining tool interactive demonstration track was created to assess the landscape of the available tools and to gauge user interest, thereby providing a two-way communication channel between NLP system developers and potential end users. The goal was to inform system designers about the performance and usability of their products and to suggest new additional features. Considering the exploratory nature of this track, the call for participation solicited teams to apply for the track, based on their system’s ability to perform COVID-19-related tasks and interest in receiving user feedback. We also recruited volunteer users to test systems. Seven teams registered systems for the track, and >30 individuals volunteered as test users; these volunteer users covered a broad range of specialties, including bench scientists, bioinformaticians and biocurators. The users, who had the option to participate anonymously, were provided with written and video documentation to familiarize themselves with the NLP tools and completed a survey to record their evaluation. Additional feedback was also provided by NLP system developers. The track was well received as shown by the overall positive feedback from the participating teams and the users. Database URL:

Date de publication
5 octobre 2022
Chatr-Aryamontri A, Hirschman L, Ross KE, Oughtred R, Krallinger M, Dolinski K, Tyers M, Korves T, Arighi CN
Référence PubMed
Database (Oxford) 2022;2022
ID PubMed
Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Marcelle-Coutu Pavilion, 2950 Chem. de Polytechnique Montreal, Quebec H3T 1J4, Canada.